Today: 20 March 2026
Subscribe
Browse Category

NASDAQ:SPRB 6 October 2025 - 19 October 2025

Spruce Biosciences Skyrockets on FDA Breakthrough – Will SPRB’s Rally Last or Fade?

Spruce Biosciences (SPRB) Skyrockets 1,300% on FDA Breakthrough News – Experts Weigh In

Spruce Biosciences shares soared over 1,300% on October 6 after its lead drug for Sanfilippo Syndrome Type B received FDA Breakthrough Therapy status. The company raised $50 million in a private placement at $68 per share. SPRB traded in the mid-$150s on October 19, up from $8 before the announcement. Analyst opinions remain split, with a consensus price target below current levels.
19 October 2025
·
Spruce Biosciences (SPRB) Skyrockets 1,300% on FDA Breakthrough – Inside the Stock Surge, Pipeline & Outlook (Oct 2025)

Spruce Biosciences (SPRB) Skyrockets 1,300% on FDA Breakthrough – Inside the Stock Surge, Pipeline & Outlook (Oct 2025)

Spruce Biosciences shares soared over 1,300% after the FDA granted breakthrough therapy designation to its lead drug for Sanfilippo Syndrome Type B. Trading was repeatedly halted amid a flood of investor interest, including public backing from Martin Shkreli. The company, recently relisted on Nasdaq, faces ongoing financial strain with just $16.4 million in cash and no significant revenue.
7 October 2025
··
Spruce Biosciences Skyrockets on FDA Breakthrough – Will SPRB’s Rally Last or Fade?

Spruce Biosciences Skyrockets on FDA Breakthrough – Will SPRB’s Rally Last or Fade?

Spruce Biosciences shares jumped over 250% intraday on Oct. 6, 2025, after the FDA granted Breakthrough Therapy Designation to its lead drug, tralesinidase alfa, for Sanfilippo Syndrome Type B. The stock rose from around $9 to $31. Spruce regained its Nasdaq listing in September following a reverse split. The company reported $16.4 million in cash as of June 30 and remains unprofitable.
6 October 2025
··

Stock Market Today

  • Meta Unveils AI Safety Tool to Boost User Engagement and Ad Revenues
    March 20, 2026, 1:13 PM EDT. Meta Platforms is launching a new AI-driven support assistant across Facebook and Instagram to enhance safety and security features. The tool aims to resolve user issues swiftly, handling scams, impersonation, privacy settings, and more within five seconds. Meta's AI focus, powered by data from over 3.58 billion daily users, is expected to increase user engagement and advertising revenues, which represent 98.6% of its app family income. This move comes amid intense competition in digital advertising from Alphabet and Amazon. Meta projects first-quarter 2026 revenues between $53.5 billion and $56.5 billion, showing potential growth of over 30% year-on-year. Alphabet's Google advertising revenue rose 13.6% in late 2025, underscoring the competitive pressure in AI-enhanced ad markets.
Go toTop